I agree that this site is using cookies. You can find further informations here.
X
Shukui Qin
196  results:
Articles (Online) X
Search for persons X
?
1

Polymorphisms in XRCC1 and XPG and response to platinum-bas..:

Sun, Xinchen ; Li, Fan ; Sun, Ning...
Lung Cancer.  65 (2009)  2 - p. 230-236 , 2009
Link: https://doi.org/10.1016/..
 
?
2

Fruquintinib plus paclitaxel versus placebo plus paclitaxel..:

Wang, Feng ; Shen, Lin ; Guo, Weijian...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
3

Hetrombopag for the management of chemotherapy-induced thro..:

Qin, Shukui ; Wang, Yusheng ; Yao, Jun...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
4

GS-005 mRECIST outcomes in EMERALD-1: a phase 3, randomized..:

Sangro, Bruno ; Kudo, Masatoshi ; Erinjeri, Joseph...
Journal of Hepatology.  80 (2024)  - p. S3 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Tislelizumab versus Sorafenib in First-Line Treatment of Un..:

Finn, Richard S. ; Kudo, Masatoshi ; Barnes, Gisoo...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
6

A phase IV study to evaluate the safety of fruquintinib in ..:

Li, Jin ; Wang, Zhiqiang ; Zhong, Haijun...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
7

Bemarituzumab as first-line treatment for locally advanced ..:

Wainberg, Zev A. ; Kang, Yoon-Koo ; Lee, Keun-Wook...
Gastric Cancer.  27 (2024)  3 - p. 558-570 , 2024
Link: https://doi.org/10.1007/..
 
?
8

A Phase 3 Study of Pembrolizumab versus Placebo for Previou..:

Qin, Shukui ; Fang, Weijia ; Ren, Zhenggang...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
9

Characterization of Tumor Responses in Patients with Unrese..:

Finn, Richard S. ; Qin, Shukui ; Piscaglia, Fabio...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
10

Reactive cutaneous capillary endothelial proliferation foll..:

Qu, Wenshu ; Wang, Feng ; Qin, Shukui..
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
11

Durvalumab or placebo plus gemcitabine and cisplatin in par..:

Oh, Do-Youn ; He, Aiwu Ruth ; Bouattour, Mohamed...
The Lancet Gastroenterology & Hepatology.  9 (2024)  8 - p. 694-704 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Bemarituzumab plus mFOLFOX6 as first-line treatment in East..:

Kang, Yoon-Koo ; Qin, Shukui ; Lee, Keun-Wook...
Gastric Cancer.  , 2024
Link: https://doi.org/10.1007/..
 
?
13

Efficacy and safety of vorolanib plus everolimus in metasta..:

Sheng, Xinan ; Ye, Dingwei ; Zhou, Aiping...
European Journal of Cancer.  178 (2023)  - p. 205-215 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Plain Language Summary of the TOPAZ-1 Study: Durvalumab and..:

Oh, Do-Youn ; He, Aiwu Ruth ; Qin, Shukui...
Future Oncology.  19 (2023)  34 - p. 2277-2289 , 2023
Link: https://doi.org/10.2217/..
 
?
15

Pembrolizumab plus chemotherapy versus placebo plus chemoth..:

Rha, Sun Young ; Oh, Do-Youn ; Yañez, Patricio...
The Lancet Oncology.  24 (2023)  11 - p. 1181-1195 , 2023
Link: https://doi.org/10.1016/..
 
1-15